Stock listing

NASDAQ:INBX Inhibrx Biosciences, Inc. Stock

Home listing (NASDAQ) of Inhibrx Biosciences, Inc.

Follow Inhibrx Biosciences, Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:INBX

$90.50 USD +5.24 (+6.1%)

Close on Oct 15, 2026

Inhibrx Biosciences, Inc. logo
Ticker
NASDAQ:INBX
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

Inhibrx Announces Participation in Upcoming Scientific Conferences

Oct 13, 2026

Inhibrx's INBRX-106 Nearly Doubles Response Rate and Achieves Interim Median PFS of 9.6 months in Phase 2 HNSCC Study

Sep 8, 2026

Inhibrx To Host Webcast Presentation to Provide Primary Endpoint Results for INBRX-106 Phase 2 First-Line HNSCC Study

Sep 4, 2026

Inhibrx Reports Second Quarter 2026 Financial Results

Aug 13, 2026

Inhibrx Biosciences Announces Amended Loan Agreement with Oxford Finance, Expanding Total Facility to $500.0 Million

Jul 16, 2026

Inhibrx Announces U.S. FDA Acceptance of BLA for Ozekibart in Patients with Conventional Chondrosarcoma

Jun 15, 2026

Inhibrx Reports First Quarter 2026 Financial Results

May 14, 2026

Inhibrx Reports Interim Phase 2 Data for INBRX-106 in First-Line HNSCC; Initial Results Demonstrate Potential Costimulatory Benefit Over PD-1 Monotherapy

May 11, 2026

Inhibrx To Host Webcast Presentation to Provide Clinical Update on INBRX-106 HexAgon Study in First Line HNSCC

May 8, 2026

Inhibrx Provides Clinical Update on Ozekibart (INBRX-109) in Late Line Colorectal Cancer

Apr 21, 2026

All Inhibrx Biosciences, Inc. news

Financings

  • Term C Loan with warrants

    Jul 16, 2026

    Closed: US$100M raised · Warrants at US$93.21 for 120 months

    Buyers: Oxford Finance LLC (funded the $100.0 million Term C Loan and received warrants to purchase 21,457 shares)

    Use of proceeds: Advancing the ozekibart (INBRX-109) and INBRX-106 programs

    Closed Jul 16, 2026

Read by 6ix AI from the company's releases

Decks

Inhibrx Biosciences, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
18 in the last 12 months · 24 in all · newest Oct 13, 2026 · oldest 2024
Decks
9 decks · latest Sep 28, 2026

Where Inhibrx Biosciences, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:INBX · Home listing · This pageNASDAQUnited StatesUSD
BOATS:INBXBOATSUnited StatesUSD

Log in to ask 6ix AI your own questions about Inhibrx Biosciences, Inc.